filament health Archives | Psychedelic Spotlight

Health Canada’s Dealer’s Licence & Section 56 Explained with Benjamin Lightburn

February 27, 2023June 2, 2024 Listen, Podcasts

Benjamin Lightburn of Filament Health discusses the ins and outs of being a licensed dealer of naturally derived psilocybin in Canada and internationally.

Vancouver Company Creates World’s First Ever Ayahuasca Pill

February 14, 2023June 2, 2024 Business, Human health, Learn

Ayahuasca pills provide users with an easily accessible, safe and convenient way to explore spiritual realms like never before.

Project Solace: The World’s Largest Medical Psilocybin Access and Data Project

July 28, 2022June 2, 2024 Business, Learn, Research

Project Solace uses real-world data to inform development of regulated psilocybin therapy, led by Canadian non-profit TheraPsil

3 Microdosing Clinical Trials to Keep an Eye On

July 27, 2022June 2, 2024 Business, Learn, Research

Does microdosing psychedelics work, or is it the placebo effect? Here are 3 microdosing clinical trials looking for answers

Psychedelic Business Spotlight – June 17

June 17, 2022June 2, 2024 Business, Learn, News, Stock Reports

This week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!

Psychedelic Business Spotlight – March 25

March 25, 2022June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: Filament Health scores 2nd psilocybin patent; a new psychedelics company emerges as one crumbles.

Psychedelic Business Spotlight: November 5

November 5, 2021June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.

FDA Approves First Clinical Trial Using Naturally Sourced Psychedelics

November 4, 2021June 2, 2024 Business, Learn

This trial, using Filament Health’s botanical drug candidates, is the first to assess the direct administration of psilocin.

Psychedelic Business Spotlight: September 10, 2021

September 10, 2021June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: major DMT development for stroke treatment; a propriety psilocybin formulation has potential to treat obesity; two more companies join the OTC Pink Market.

Psychedelic Business Spotlight: September 3, 2021

September 3, 2021June 2, 2024 Business, Learn, Stock Reports

“Magic Truffle” producer and distributor Red Light Holland has had a very busy week, and Filament Health files a “milestone” patent.

filament health